AnHorn Medicines Advances AH-008 into Phase I Trial for CIPN Prevention
Irvine, California, USA — July 27, 2026 July 27, 2026 – AnHorn Medicines has announced the successful first subject...
European Union
Advertisement
Zevra Therapeutics to Seek EU Re-Examination for Arimoclomol After CHMP Opinion
BOSTON – July 24, 2026 Zevra Therapeutics, Inc. has announced that the European Medicines Agency’s (EMA) Committee for Medicinal...
Regentis Wins European Approval for New GelrinC Process
HERZLIYA, Israel, July 15, 2026 Regentis Biomaterials announced that it has received approval from the European Notified Body for...
AbbVie Secures EU Approval for MAVIRET in Acute Hepatitis C
NORTH CHICAGO, Ill., June 23, 2026 AbbVie announced that the European Commission has approved MAVIRET® (glecaprevir/pibrentasvir) for the treatment...
Advertisement
